QUARTERLY RESULTS
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 04
3427.35
+203.70 (+ 6.32%)
Volume
12978
Prev. Close
3223.65
Open Price
3300.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 04
3420.00
+174.90 (+ 5.39%)
Volume
269490
Prev. Close
3245.10
Open Price
3259.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
57936.86
|
P/BV
|
34.64
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3456/1921
|
FV/ML
|
10/1
|
P/E(X)
|
62.46
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.58
|
(₹ in Crs.)
| Net Sales/Income from operations | 966.08 | 946.36 | 1000.05 | 811.00 | 910.87 |
| Total Income From Operations | 966.08 | 946.36 | 1000.05 | 811.00 | 910.87 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 108.35 | 91.93 | 137.25 | 133.33 | 192.29 |
| Purchase of Traded Goods | 291.40 | 164.23 | 216.74 | 172.74 | 255.74 |
| Increase/Decrease in Stocks | -53.41 | 95.28 | 22.62 | -13.26 | -98.90 |
| Employees Cost | 152.97 | 124.74 | 150.71 | 151.28 | 172.83 |
| Depreciation | 14.72 | 18.80 | 16.86 | 16.41 | 18.10 |
| Other Expenses | 136.03 | 180.00 | 153.78 | 137.49 | 133.60 |
| Total Expenses | 650.06 | 674.98 | 697.96 | 597.99 | 673.66 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 316.02 | 271.38 | 302.09 | 213.01 | 237.21 |
| Other Income | 39.46 | 35.06 | 32.19 | 35.85 | 29.87 |
| P/L Before Interest, Excpt. Items & Tax | 355.48 | 306.44 | 334.28 | 248.86 | 267.08 |
| Interest | 0.58 | 0.09 | 0.27 | 0.37 | 0.77 |
| P/L Before Exceptional Items & Tax | 354.90 | 306.35 | 334.01 | 248.49 | 266.31 |
| Exceptional Items | 0.00 | 0.00 | 4.69 | 0.00 | 2.40 |
| P/L Before Tax | 354.90 | 306.35 | 338.70 | 248.49 | 268.71 |
| Tax | 94.76 | 77.77 | 90.01 | 66.84 | 75.63 |
| P/L After Tax from Ordinary Activities | 260.14 | 228.58 | 248.69 | 181.65 | 193.08 |
| Net Profit/Loss For the Period | 260.14 | 228.58 | 248.69 | 181.65 | 193.08 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 15.35 | 13.49 | 14.68 | 10.72 | 11.29 |
| Diluted EPS (Rs.) | 15.35 | 13.49 | 14.68 | 10.72 | 11.39 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 15.35 | 13.49 | 14.68 | 10.72 | 11.29 |
| Diluted EPS (Rs.) | 15.35 | 13.49 | 14.68 | 10.72 | 11.39 |
| | | | | | |
| PBITOE Margin (%) | 32.71 | 28.67 | 30.20 | 26.26 | 26.04 |
| PBTE Margin (%) | 36.73 | 32.37 | 33.39 | 30.63 | 29.23 |
| PBT Margin (%) | 36.73 | 32.37 | 33.86 | 30.63 | 29.50 |
| PAT Margin (%) | 26.92 | 24.15 | 24.86 | 22.39 | 21.19 |